Vitamin D in chronic liver disease

CS Stokes, DA Volmer, F Grünhage… - Liver …, 2013 - Wiley Online Library
Chronic liver disease (CLD) and several related extrahepatic manifestations such as hepatic
osteodystrophy are associated with deficiency of vitamin D, which has therefore been …

Liver fibrosis in alcoholic liver disease

R Bataller, B Gao - Seminars in liver disease, 2015 - thieme-connect.com
Excessive alcohol consumption causes a wide spectrum of liver disease, ranging from
simple steatosis to severe forms of liver injury such as steatohepatitis, liver fibrosis, cirrhosis …

Rodent models of alcoholic liver disease: of mice and men

E Brandon-Warner, LW Schrum, CM Schmidt… - Alcohol, 2012 - Elsevier
Alcoholic liver disease (ALD) is a major cause of acute and chronic liver disease worldwide.
The progressive nature of ALD is well described; however, the complex interactions under …

The functional role of micro RNA s in alcoholic liver injury

K McDaniel, L Herrera, T Zhou… - Journal of cellular …, 2014 - Wiley Online Library
The function of micro RNA s (mi RNA s) during alcoholic liver disease (ALD) has recently
become of great interest in biological research. Studies have shown that ALD associated mi …

[HTML][HTML] Celecoxib attenuates hepatocyte apoptosis by inhibiting endoplasmic reticulum stress in thioacetamide-induced cirrhotic rats

W Su, Y Tai, SH Tang, YT Ye, C Zhao… - World Journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Endoplasmic reticulum (ER) stress is an important mechanism in the
progression of chronic and acute liver diseases, especially in the progression and recovery …

Therapeutic application of micellar solubilized xanthohumol in a western-type diet-induced mouse model of obesity, diabetes and non-alcoholic fatty liver disease

A Mahli, T Seitz, K Freese, J Frank, R Weiskirchen… - Cells, 2019 - mdpi.com
Xanthohumol (XN), a prenylated chalcone from hops, has been reported to exhibit a variety
of health-beneficial effects. However, poor bioavailability may limit its application in the …

Adverse outcome pathway development from protein alkylation to liver fibrosis

T Horvat, B Landesmann, A Lostia, M Vinken… - Archives of …, 2017 - Springer
In modern toxicology, substantial efforts are undertaken to develop alternative solutions for
in vivo toxicity testing. The adverse outcome pathway (AOP) concept could facilitate …

A 3D alcoholic liver disease model on a chip

JS Lee, BH Choi, DY No, GH Lee, S Lee… - Integrative …, 2016 - academic.oup.com
Alcohol is one of the main causes of liver diseases, and the development of alcoholic liver
disease (ALD) treatment methods has been one of the hottest issues. For this purpose …

Hepatic stellate cell-derived exosomes modulate macrophage inflammatory response

JH Benbow, E Marrero, RM McGee… - Experimental cell …, 2021 - Elsevier
Background Hepatic stellate cell (HSC) differentiation/activation is central to liver fibrosis
and is innately linked to the immune response to liver injury. Exosomes (EXOs) are …

In vivo biocompatibility and biodegradation of a novel thin and mechanically stable collagen scaffold

A Rahmanian‐Schwarz, M Held… - … research Part A, 2014 - Wiley Online Library
The demand for scaffolds comprised of natural materials such as collagen has increased in
recent years. However, many scaffolds rely on chemical or physical modifications in order to …